Full-Time

Senior Research Associate

Confirmed live in the last 24 hours

Karius

Karius

51-200 employees

Non-invasive diagnostic tests for infections

Biotechnology
Healthcare

Senior

San Carlos, CA, USA

This position is onsite in Redwood City, CA.

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree in Biology, Molecular Biology, Genetics or related field.
  • A minimum of 4 to 6 years of industry-related laboratory experience.
  • Strong molecular biology skills; e.g. DNA/RNA purification, nucleic acids hybridization, PCR, qPCR.
  • Experience with NGS (preparing libraries, running NGS instruments); NGS data processing is a big plus.
  • Critical thinking, attention to detail, and thorough record-keeping.
  • Proficient in the use of Microsoft Office Excel and Word.
Responsibilities
  • Responsible for all phases of manufacturing and qualifying in-house reagents for the current commercial products (including reagent build scheduling, material procurement, and reagent formulation and filling).
  • Execute development experiments of moderate to high complexity.
  • Maintain and stock reagent manufacturing and R&D laboratories.
  • Responsible for detailed documentation of all processes according to the Karius quality management system.
  • Work comfortably in a fast-paced, collaborative, startup environment.
  • May be required to perform other duties as assigned.
Desired Qualifications
  • Ability to work independently and collaboratively with team members.
  • Highly goal-driven and have demonstrated the ability to effectively prioritize and focus on time-sensitive objectives.
  • Strong problem-solving skills.
  • Excellent teamwork and motivation skills are essential.
  • Excellent organizational, record-keeping and communication (verbal and written) skills.
  • Strong work ethic to generate high quality work under tight deadlines.

Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, which detects over 1,000 pathogens from a single blood sample. This non-invasive test is quick and helps clinicians treat hospitalized patients by reducing the need for multiple invasive tests that can delay treatment. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, providing insights into infections. Karius sells these tests to healthcare providers, aiming to save lives and lower healthcare costs by offering a faster alternative to traditional methods. Their proprietary machine learning algorithms analyze genomic data in real time, with continuously updated reference genome databases, ensuring they remain leaders in infectious disease diagnostics.

Company Stage

Series C

Total Funding

$311.3M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Karius secured $100M to expand its test beyond 400 U.S. hospitals.
  • FDA Breakthrough Device Designation boosts credibility and market potential.
  • Growing demand for non-invasive diagnostics aligns with Karius's offerings.

What critics are saying

  • Competition from AlphaFold 3 could overlap with Karius's genomic insights.
  • Rapid AI advancements by competitors may outpace Karius's technology.
  • Reliance on continuous funding rounds indicates potential financial instability.

What makes Karius unique

  • Karius Test detects over 1,000 pathogens from a single blood sample.
  • The test uses advanced genomics and AI for rapid, non-invasive diagnostics.
  • Karius's proprietary algorithms analyze genomic data in real time.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Hybrid Work Options